SEC Form 4 · accession 0001624073-16-000010
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alistair Macdonald
Officer — Chief Operating Officer
Period of report
Aug 1, 2016
Accepted (ET)
Aug 2, 2016 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Aug 1, 2016 | A | 35,553 | $0.00 | A | 54,229 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $42.76 | Aug 1, 2016 | A | 35,553 | A | — | Aug 1, 2026 | Class A Common Stock | 35,553 | 35,553 | D |
Explanation of responses
- F1In connection with the reporting person's promotion to Chief Executive Officer of the Issuer effective October 1, 2016 (the "Promotion"), the reporting person received an award of restricted stock units which vests in four equal annual installments beginning on August 1, 2017, subject to continued employment.
- F2In connection with the Promotion, the reporting person received an option award. The shares subject to this option vest in four equal annual installments beginning on August 1, 2017, subject to continued employment.